Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Sunday, March 21 2010 7:09pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > Vaxon Biotech Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Vaxon Biotech Company Profile
Vaxon Biotech is a biopharmaceutical company focused on the treatment of cancers and related malignancies. Disease targets include breast, lung, pancreatic, and prostate cancer. The company's claim to fame is its development of optimized cryptic peptide antigens (substances that trigger protein responses in the immune system), which have shown early progress in the immune response against these cancers. The company's development products are classified as therapeutic vaccines and are developed to trigger the immune system to attack malignant cells in solid tumors while steering clear from normal cells.
Contact Information
Address: 2 rue Gaston Crémieux
91057 Évry Cedex, France
Phone:+33-1-60-78-92-10
Fax:+33-1-60-78-92-19
Key People
Founder, President, and Chief Science Officer: Kostas Kosmatopoulos
Industry Information
Sector: Healthcare
Industry: Biotechnology
Top Competitors
Antigenics Inc. (agen)
Dendreon Corporation (dndn)
TRANSGENE S.A.
 


Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2010 Morningstar, Inc. All Rights Reserved. Company information © 2010 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2010, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?